Motif Bio PLC Holding(s) in Company (3015R)
December 08 2016 - 2:45AM
UK Regulatory
TIDMMTFB
RNS Number : 3015R
Motif Bio PLC
08 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Motif Bio plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- ---------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------------------------
Other (please Issue of ADSs on Initial Public Offering Y
specify): on Nasdaq
--------------------------------------------------------- ---------------------------------------------
3. Full name of person(s) Sabby Healthcare Master Fund,
subject to the Ltd
notification obligation: Sabby Management, LLC
(iii) Hal Mintz
----------------------------------------------------------- -----------------------------------------------
4. Full name of shareholder(s) Sabby Healthcare Master Fund,
(if different from 3.):(iv) Ltd
----------------------------------------------------------- -----------------------------------------------
5. Date of the transaction 23 November 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- -----------------------------------------------
6. Date on which issuer 30 November 2016
notified:
----------------------------------------------------------- -----------------------------------------------
7. Threshold(s) that is/are >9%
crossed or
reached: (vi, vii)
----------------------------------------------------------- -----------------------------------------------
8. Notified details:
-------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------ ------------------------------ ---------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------ -------------- -------------- ------------- --------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------ ------------ ------------ ------------- -------- ----------- -------- ---------
B: Qualifying Financial Instruments
-------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
-------------- ------------- ----------------------------- -------------------- -------------------
American
Depositary
Shares 17,191,980 9.52
-------------- ------------- ----------------------------- -------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
------------- ------------- ------------- -------------- --------------------- -------------------
Nominal Delta
------------- ------------- ------------- -------------- --------------------- -------- ---------
Total (A+B+C)
-------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------- --------------------------------------------------------
17,191,980 9.52
--------------------------------------------- --------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------
Hal Mintz is manager of Sabby Management LLC, which
serves as the investment manager of Sabby Healthcare
Master Fund Ltd. Each of Sabby Management, LLC and Hal
Mintz disclaims beneficial ownership over the securities
listed except to the extent of their pecuniary interest
therein.
Proxy Voting:
---------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- ------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ------------------
13. Additional information:
------------------------------------------------------------- ------------------
14. Contact name: Robert Grundstein
------------------------------------------------------------- ------------------
15. Contact telephone number: 646-307-4500
------------------------------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLIFSDFLLTIIR
(END) Dow Jones Newswires
December 08, 2016 02:45 ET (07:45 GMT)
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Apr 2024 to May 2024
Motif Bio (LSE:MTFB)
Historical Stock Chart
From May 2023 to May 2024
